Brett Knoblauch

Darren Aftahi

John Todaro

Joseph Flynn

Joseph Vafi

Kevin Dede

Jonathan Petersen

Paul Golding

Rosemary Sisson

Bill Papanastasiou

George Sutton

Lucas Pipes

Nick Giles

Stephen Glagola

Tyler DiMatteo

Gregory Lewis

Joe Vafi

Steven Glagola

- CoreWeave's stock has **declined over 40% since July** due to **insider selling** following its IPO lockup period and concerns regarding its **$9 billion all-stock acquisition deal for Core Scientific**.  **[1839341_5e6edcddd8f34d4a97f46e7a74dc859b]** 
- Key insiders, including **CEO Michael Intrator** and **Corporate Secretary Kristen McVeety**, have sold millions of shares, with analysts suggesting the rapid pace of selling indicates **overvaluation** and that CoreWeave is a **risky investment** due to **mounting debt**.  **[1839341_5e6edcddd8f34d4a97f46e7a74dc859b]** 
- The drop in CoreWeave's share price has **reduced the value of the Core Scientific acquisition deal**, prompting Core Scientific shareholders to **demand better terms**.  **[1839341_5e6edcddd8f34d4a97f46e7a74dc859b]** 
- Despite these challenges, CoreWeave remains focused on **expanding its AI infrastructure capabilities** and holds a **Moderate Buy consensus** from Wall Street analysts for its longer-term potential.  **[1839341_5e6edcddd8f34d4a97f46e7a74dc859b]**

CoreWeave Stock Declines Amid Insider Selling and Acquisition Renegotiations

Core Scientific, Inc./tx (CORZ)